DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Cassidy J, Douillard JY, Twelves C. et al.
Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes’ C colon cancer: the X-ACT trial.
Br J Cancer 2006; 94: 1122-1129
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.